Tuttle Mark K, Pinto Duane S
Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim Road, West Campus, Baker 4, Boston, MA 02215, USA.
Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim Road, West Campus, Baker 4, Boston, MA 02215, USA.
Interv Cardiol Clin. 2019 Apr;8(2):225-234. doi: 10.1016/j.iccl.2019.01.001.
ST-elevation myocardial infarction (STEMI) patients with multivessel disease and without shock are a common clinical entity, but the best approach to nonculprit vessel lesions remains controversial. In contrast, STEMI patients with shock do not appear to benefit from primary multivessel percutaneous coronary interventions (PCIs) during the index procedure. The optimal treatment strategy in a given STEMI patient involves an individualized approach, incorporating clinical, hemodynamic, and angiographic/imaging parameters. Patients with STEMI and cardiogenic shock may benefit from therapies other than PCI, such as mechanical cardiovascular support.
患有多支血管病变且无休克的ST段抬高型心肌梗死(STEMI)患者是常见的临床情况,但对于非罪犯血管病变的最佳处理方法仍存在争议。相比之下,患有休克的STEMI患者在首次手术期间似乎无法从初次多支血管经皮冠状动脉介入治疗(PCI)中获益。特定STEMI患者的最佳治疗策略需要个体化方法,综合考虑临床、血流动力学以及血管造影/影像学参数。患有STEMI和心源性休克的患者可能从PCI以外的治疗中获益,如机械性心血管支持。